Stocks
Quest Diagnostics IncorporatedDGX
NYSEHealthcareDiagnostics & Research$199.70-0.59%
A leading provider of diagnostic testing, information, and services, Quest Diagnostics operates one of the largest clinical laboratories in the U.S. Investors monitor the company for its role in preventive care, chronic disease management, and COVID-19 testing capabilities. The firm's scale and data analytics offerings position it as a key player in lab-based diagnostics.
Market Cap: $22.2B52W Range: $157.20 – $213.50
Congressional Interest in Quest Diagnostics Incorporated (DGX)
15 members of Congress have disclosed 50 trades in Quest Diagnostics Incorporated (DGX), a Healthcare company. The buy/sell breakdown shows 17 purchases versus 33 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
15
Buys
17
Sells
33
Who in Congress Is Trading DGX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-30 | Alan Armstrong | buy | $1K – $15K |
| 2026-03-27 | Alan Armstrong | buy | $1K – $15K |